SUMMARY Beta adrenergic blocking drugs in hypertrophic cardiomyopathy provide symptomatic relief but their effect on long-term prognosis is uncertain.
For the past two decades beta adrenergic blocking drugs have been widely used in the treatment of hypertrophic cardiomyopathy and since early trials they have been shown to produce important symptomatic benefits.'-3 A double blind trial of practolol, propranolel, and a placebo has suggested that beta blockade was associated with amelioration or disappearance of dyspnoea, anginal pain, and syncope in severely symptomatic patients4 but unfortunately beta adrenergic blockade cannot be guaranteed to prevent sudden death.5 6 Hypertrophic cardiomyopathy is a disease characterised by massive hypertrophy and impaired distensibility of the left ventricle which leads to abnormal Accepted for publication 25 March 1982 diastolic filling with a small systolic cavity and a very stiff ventricle. [7] [8] [9] We believe that this abnormal diastolic filling is the most important factor in determining symptoms and prognosis regardless of whether a gradient between the outflow tract of the left ventricle and aorta is present or not.
It has been known that beta adrenergic stimulation increases the pressure gradient between left ventricle and aorta and decreases the calculated orifice size of the outflow tract of the left ventricle. Such stimulation may be produced or be augmented by exercise, tachycardia, emotion, and drugs that have a positive inotropic effect. I0 1 1 Therefore it was thought initially that this improvement of symptomatology was the result of a decreased pressure gradient across the outflow tract 204 group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from with a lower cardiac output, in proportion to the decrease in heart rate,'2 but subsequent workers have shown by invasive13 14 and non-invasive4 615 methods that the important mechanism of action of beta blockade was an increase in left ventricular distensibility, allowing the inflow of an increased volume of blood during diastole.
One of the difficulties in interpreting the value of these drugs has been the lack of objective assessment of the results of oral treatment.
Therefore in the present study an attempt was made to study filling and relaxation, the two main interdependent events in early diastole, in hypertrophic cardiomyopathy on and off oral beta adrenergic blocking drugs, in order to detect any important changes after beta blockade.
We have studied the events during diastole using simultaneous non-invasive recordings of the left ven (Fig. 1) .
The subjects lay comfortably in the left lateral recumbent position in the moveable angiography cradle with their head and shoulders raised (15-20' During the examination of each patient a second phonocardiogram was obtained from the base of the heart using a second crystal transducer simultaneously with the carotid pulse in order to define accurately the aortic component of the second heart sound. 
Results
(1) Heart rate: the mean heart rate of patients off treatment was 71*6±16-6 beats per minute. Fig. 2 shows that the heart rate decreased significantly after beta blockade in all but four patients. The mean heart rate on beta blockade was 58-1 ± 10 9 beats per minute (p<0O001). (2) Rapid relaxation period: A2-0. The mean rapid relaxation period for all patients was prolonged after beta blockade from 178X0+42X9 to 185*0+47*7 ms (Table 2 ). Though overall there was an increase of rapid relaxation period reflecting prolonged relaxation after beta blockade, this was not significant (p>0-15). As shown in Fig. 3 From the mitral valve opening to the 0 point of the apexcardiogram when the pressure continues to drop (Fig. 1) the rate of relaxation of the left ventricle is greater than the rate of blood filling the left ventricular cavity as a result of which there is a "sucking" effect of the blood coming from the left atrium to the left ventricle. This is the active suction period when most of the left ventricular filling occurs,2' which goes with a considerable increase in dimension during downstroke of the apexcardiogram21 22 and rapid thinning of the posterior wall and interventricular septum. Therefore the longer this period is the better will be the left ventricular filling.
There is controversy about this period especially between those who believe that the relaxation and filling are purely passive processes, determined by venous pressure (vis-a-tergo of Harvey) and those who believe (as this study suggests) that diastolic filling is governed, at least in part, by an active process originating in the ventricular myocardium. This is shown by the fact that the mitral valve opens before minimum ventricular pressure is reached, so that early diastolic filling is associated with a reduction, rather than an increase, in left ventricular pressure. Katz23 concluded that it reflects a sucking effect of the left ventricle drawing blood into its chamber, and more recently2426 further evidence has been produced for such diastolic suction. Hammermeister and Warbasse27 have shown that during this period (Mo-O), more than 50% of filling is already completed. Thus this period is really the "rapid filling wave" which is not the interval from 0 to F point of the apexcardiogram as was previously described; it was thought in the pre-echocardiographic era that the O point was coincident with mitral valve opening, since in many cases it corresponded with the opening snap in patients with mitral stenosis.28
From the 0 point to the F point of the apexcardiogram the rate of filling is greater than the rate of relaxation and this is why the left ventricular pressure starts to rise (Fig. 1 ) though in absolute terms the volume of blood coming to the left ventricle is less than during the active suction period. The interval from mitral valve opening until the F point of the apexcardiogram is defined as the rapid filling period. Thus the 0 point of the apexcardiogram is the "turning point" where the rate of filling and the rate of relaxation are in equilibrium.
The results of the present work using these techniques suggest that there was no significant prolongation of the rapid relaxation period (Fig. 3 ) or significant shortening of the isovolumic relaxation period (Fig. 4) , . '-(apex) AG-_I Alvares, Goodwin ever, a significant increase in the interval from mitral valve opening to the 0 point of the apexcardiogram as shown in Fig. 5 when most of the left ventricular filling occurs. Prolongation of this period occurred in 22 patients (74%) but it remained the same or was shortened in one (3%) and in seven (23%), respectively. Thus beta blockade is usually valuable in hypertrophic cardiomyopathy since increase in left ventricular filling is achieved at a much lower pressure and this may explain the relief of symptoms. In addition because of this improved early filling, there is less distension of the left atrium, thus possibly preventing the occurrence of atrial fibrillation. The atrial beat also tends to be less powerful after beta blockade.
Shortening of the isovolumic relaxation period possibly contributes to the increase of the Mo-O interval. The former had a variable response after beta blockade, but showed an overall shortening which was not significant. Of 22 patients who had an increased active suction period, 11 had a shortened isovolumic relaxation period. In the remaining 11 it was prolonged or remained unchanged. In addition the increase of active suction period was not directly proportional to the shortening of the isovolumic relaxation period in the 11 patients where this period was shortened after treatment.
Thus, possibly the main reason for prolongation of the Mo-O interval is that the equilibrium point (O point) is reached much later because of relaxation at a much lower pressure as a consequence of which there is increased filling in early diastole. These results confirm the work of de mitral valve after beta blockade probably related to increased ventricular filling. The consequence of this increased filling can be seen in Fig. 6 where after treatment there was an increase in stroke volume, as shown by increased aortic valve opening.
This increase in the active suction period was not affected by age, by sex, by the type or amount of the drug, by blood pressure, or by heart rate. This can be seen in Fig. 7 where a patient with hypertrophic cardiomyopathy and in atrial fibrillation with different RR intervals had almost constant rapid relaxation period and isovolumic relaxation period. In this group of 30 patients the coefficient of correlation between the heart rate and the diastolic time intervals in early diastole (A2-O, A2-Mo, Mo-O) was extremely low. Nor was this increase of active suction period affected by the presence of a gradient to the outflow tract of the left ventricle.
The effect of beta blockade in lowering the heart rate should not be underestimated because an appreciable amount of filling occurs during the slow relaxation period, diastasis, and the atrial component of diastole which are all related closely to the heart rate. Indeed, clinically there is pronounced deterioration of these patients when they are in atrial fibrillation. 
